
Eurobio Scientific
ALERS | PA
Overview
Corporate Details
- ISIN(s):
- FR0004054435 (+2 more)
- LEI:
- 969500IQEUEH806GE257
- Country:
- France
- Address:
- 7 AVENUE DE SCANDINAVIE, 91940 LES ULIS
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
The Eurobio Scientific group is an integrated French player in in vitro diagnostics. Today, as the leader in the French in-vitro diagnostics market, the Eurobio Scientific group is pursuing its development by intervening from research to the marketing of specialty diagnostic products and products in the life sciences field. Eurobio Scientific's know-how is based on the marketing of specialty diagnostic tests to hospital and private medical laboratories. The group is also recognised in France as the market leader in HLA tests for transplantation. Eurobio Scientific also markets exclusive tests and automated solutions designed by our foreign industrial partners (American, Korean, European, etc.) in the fields of infectious diseases, autoimmunity and quality control.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-01 17:45 |
M&A Activity
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
|
French | 177.0 KB | |
2025-07-01 17:45 |
M&A Activity
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
|
English | 173.7 KB | |
2025-06-17 16:59 |
Major Shareholding Notification
Franchissement de seuils
|
French | 116.1 KB | |
2025-05-19 19:16 |
Major Shareholding Notification
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
|
French | 135.1 KB | |
2025-05-19 19:16 |
Major Shareholding Notification
Eurobio Scientific: EB Development rises above 90% threshold
|
English | 134.8 KB | |
2025-04-29 21:00 |
Report Publication Announcement
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
|
French | 610.9 KB | |
2025-04-28 17:46 |
Earnings Release
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
|
French | 216.3 KB | |
2025-04-28 17:46 |
Earnings Release
Eurobio Scientific: 2024 annual results
|
English | 231.2 KB | |
2025-03-12 17:35 |
M&A Activity
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
|
French | 131.2 KB | |
2025-03-12 17:35 |
M&A Activity
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
|
English | 133.7 KB | |
2025-03-04 20:03 |
Regulatory News Service
Eurobio Scientific : résiliation du contrat de liquidité
|
French | 134.6 KB | |
2025-01-15 17:46 |
Report Publication Announcement
Eurobio Scientific : calendrier des publications financieres 2025
|
French | 598.6 KB | |
2024-12-19 10:30 |
Declaration of Voting Results & Voting Rights Announcements
Eurobio Scientific : EB Development obtient une très large majorité du capital …
|
French | 918.1 KB | |
2024-12-19 10:30 |
M&A Activity
Eurobio Scientific: EB Development obtains a significant majority of the capita…
|
English | 917.9 KB | |
2024-12-06 09:58 |
Major Shareholding Notification
Franchissement de seuils
|
French | 213.2 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-12-18 | N/A | Other | Buy | 1,000 | 15,180.00 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |